Emirates Oncology Society – EOS shared a post on LinkedIn:
“Join EOS for an impactful meeting on Reconsidering the Reflex Action in Treatment for EGFR-Mutated NSCLC!
Tuesday, 20 October 2026 | Virtual | CME Hours
Time: UAE: 07:00 PM | London : 04:00 PM | NY: 11:00 AM |Kuwait: 06:00 PM | Qatar: 06:00 PM
Moderator: Dr. Hassan Jaafar
Speakers: Dr. Emad Dawoud | Dr. Dina Hamza | Dr. Dalia Elshorbagy| Dr. Hassan Shahryar | Dr. Syed Karim
Endorsed by: Emirates Oncology Society (EOS) and Emirates Medical Association (EMA)
Sponsored by: Johnson & Johnson
Managed by: Conveners.”
You can also read: Osimertinib Shows Sustained 8-Year Survival Benefit in Early-Stage EGFR-Mutated NSCLC in ADAURA
